Pardeep Nijhawan insider trades

Open-market stock purchases and sales by Pardeep Nijhawan, Chief Executive Officer at Edesa Biotech, Inc, from SEC Form 4 filings since Jun 7, 2019.

Track record: 96% of 25 scored buys are up 5% or more since purchase, averaging +93%.

Recent trades

DateStockTradeValue
Jun 16, 2026EDSA Edesa Biotech, IncBought (not open market)$800K
Jun 1, 2026EDSA Edesa Biotech, IncBought (not open market)—
May 27, 2026EDSA Edesa Biotech, IncBought (not open market)—
May 1, 2026EDSA Edesa Biotech, IncBought (not open market)—
Apr 1, 2026EDSA Edesa Biotech, IncBought (not open market)—
Mar 10, 2026EDSA Edesa Biotech, IncBought$6.6K
Mar 5, 2026EDSA Edesa Biotech, IncBought$39K
Mar 4, 2026EDSA Edesa Biotech, IncBought$42.6K
Mar 3, 2026EDSA Edesa Biotech, IncBought$36.3K
Mar 2, 2026EDSA Edesa Biotech, IncBought$4K
Mar 2, 2026EDSA Edesa Biotech, IncBought$2.3K
Mar 2, 2026EDSA Edesa Biotech, IncBought (not open market)—
Feb 27, 2026EDSA Edesa Biotech, IncBought$66.7K
Feb 26, 2026EDSA Edesa Biotech, IncBought$32.5K
Feb 19, 2026EDSA Edesa Biotech, IncBought (not open market)—
Feb 2, 2026EDSA Edesa Biotech, IncBought (not open market)—
Jan 5, 2026EDSA Edesa Biotech, IncBought (not open market)—
Dec 1, 2025EDSA Edesa Biotech, IncBought (not open market)—
Nov 3, 2025EDSA Edesa Biotech, IncBought (not open market)—
Oct 2, 2025EDSA Edesa Biotech, IncBought (not open market)—

Companies traded

  • EDSA Edesa Biotech, Inc: 27 buys, last Jun 16, 2026

Get free alerts when Pardeep Nijhawan files a new trade →